Apr 8, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,805 views The risk of side effects with GLP-1 therapies varies widely among patients, yet treatment decisions often overlook this variability
Some clinical studies have shown detrimental effects of DPP-4 inhibitors on bone [13, 16, 18], with one study showing no effects [110]
Weight loss medications have changed the way people approach long-term weight management
Key Takeaways Glutathione S Transferase (GST) is a superfamily of enzymes essential for detoxification processes
FDA advisory committee votes are recommendations